Do all targeted drugs for nasopharyngeal carcinoma work?

Targeted drug therapy for nasopharyngeal carcinoma is through intravenous infusion, and the commonly used drug is nimotuzumab. The treatment of nasopharyngeal carcinoma mainly includes drug radiotherapy and comprehensive treatment, and its standard treatment mode is synchronous chemoradiotherapy combined with targeted therapy.

Is nosebleed from nasopharyngeal carcinoma serious?

Generally speaking, nasopharyngeal cancer has symptoms of nosebleeds, which belongs to the early stage of the disease. The early symptoms are mainly runny nose, runny nose and swollen lymph nodes in the neck. It is recommended to diagnose and treat in time to avoid worsening of the disease. If patients with nasopharyngeal cancer have nosebleeds, it is considered that the tumor has ruptured and bled, or the tumor has involved the nasal mucosa, or caused nasal mucosal infection. Nasal endoscopy or electronic nasopharyngeal endoscopy is required for examination and diagnosis, and targeted treatment is carried out according to the specific situation.

Can nasopharyngeal cancer spread?

Nasopharyngeal carcinoma is a malignant tumor that is prone to recurrence and metastasis. It can cause metastasis to any part of the body through lymphatic metastasis and blood metastasis. If metastasis occurs, salvage treatment can usually only be performed in the later stages of the disease to prolong survival and improve the quality of life. The growth of nasopharyngeal carcinoma is mainly poorly differentiated carcinoma or undifferentiated carcinoma, which is highly malignant and easy to spread around or metastasize to distant places. Early detection and treatment are required. Since nasopharyngeal carcinoma is sensitive to radiation, early treatment has a good effect.